Cardinal Health and Ohio State opened the doors this month to the new Cardinal Health Translational Research Center for Molecular Imaging Pharmaceuticals, a central resource with the latest technology to advance the molecular imaging industry. Located at Ohio State’s Wright Center of Innovation in Biomedical Imaging in the Ohio State Research Park on west campus, the center will combine Ohio State’s research capabilities with Cardinal Health’s manufacturing and commercialization expertise for molecular imaging agents. Ohio State researchers will be able to create new molecular imaging agents in Positron Emission Tomography (PET imaging). As new imaging pharmaceuticals move through the drug approval pipeline, Cardinal Health will support their development, manufacturing and dispensing for clinical drug trials in Ohio and across its national network of radiopharmaceutical facilities. This one-stop-shop facility holds a radiopharmacy, state-of-the-art training center for nuclear pharmacists, a biomarker manufacturing facility and two cyclotrons.